Decreased Expression of CD95 (FAS/APO-1) on CD4+ T-lymphocytes from Participants with Autism

被引:0
|
作者
Henrik A. Engstrom
Sten Ohlson
E. Gene Stubbs
Alma Maciulis
Virgil Caldwell
J. Dennis Odell
Anthony R. Torres
机构
[1] University of Kalmar,Department of Chemistry and Biomedical Sciences
[2] University of Oregon,Child Development and Rehabilitation Center
[3] Utah State University,Center for Persons with Disabilities, Biology Department
关键词
autism; apoptosis; FAS; CD95; APO-1;
D O I
暂无
中图分类号
学科分类号
摘要
Although autism remains an enigmatic disease, there is mounting evidence that the immune system plays an important role in the pathogenesis. Immune system involvement is apparently widespread as numerous humoral and cellular abnormalities have been reported in both the innate and adaptive responses. Fas (CD95/APO-1) is a type I cell-surface protein from the TNF/NGF-R superfamily present on the surface of many immune related cells. Fas activation is instrumental in starting a complicated chain of events that results in programmed cell death (apoptosis) by DNA fragmentation. Preliminary data is presented, which indicate that subjects with austism have lower levels of Fas on their CD4+ helper T cells (p = .048) than have normal subjects. Data also indicates subjects with autism have significantly higher levels of soluble Fas (p = .01) than have normal subjects. A maturing individual must eliminate cells for proper morphogenesis to occur. Preliminary data suggest that faulty apoptosis may be involved in the pathogenesis of autism.
引用
收藏
页码:155 / 163
页数:8
相关论文
共 50 条
  • [21] Fas (CD95, Apo-1) Ligand Gene Transfer
    Salah-Eddine Lamhamedi-Cherradi
    Youhai Chen
    Journal of Clinical Immunology, 2001, 21 : 24 - 29
  • [22] FasL-Fas/APO-1(CD95)系统
    孙长凯
    鞠躬
    生理科学进展, 1997, (02) : 42 - 44
  • [23] Two CD95 (APO-1/Fas) signaling pathways
    Scaffidi, C
    Fulda, S
    Srinivasan, A
    Friesen, C
    Li, F
    Tomaselli, KJ
    Debatin, KM
    Krammer, PH
    Peter, ME
    EMBO JOURNAL, 1998, 17 (06): : 1675 - 1687
  • [24] CD95 (APO-1/Fas) and Parkinson's disease
    Hartmann, A
    Hunot, S
    Hirsch, EC
    Hirsch, C
    ANNALS OF NEUROLOGY, 1998, 44 (03) : 425 - 425
  • [25] Protein kinase C regulates Fas (CD95/APO-1) expression
    Wang, RX
    Zhang, LY
    Yin, DL
    Mufson, A
    Shi, YF
    JOURNAL OF IMMUNOLOGY, 1998, 161 (05): : 2201 - 2207
  • [26] Fas (CD95, Apo-1) ligand gene transfer
    Lamhamedi-Cherradi, SE
    Chen, YH
    JOURNAL OF CLINICAL IMMUNOLOGY, 2001, 21 (01) : 24 - 29
  • [27] CD95 (APO-1/Fas)-induced hepatocyte death
    Galle, PR
    Strand, S
    Muller, M
    Hug, H
    Otto, G
    Hofmann, WJ
    Krammer, PH
    Stremmel, W
    AUTOIMMUNE LIVER DISEASE, 1997, : 8 - 12
  • [28] Mechanisms of CD95 (APO-1/Fas)-mediated apoptosis
    Peter, ME
    Krammer, PH
    CURRENT OPINION IN IMMUNOLOGY, 1998, 10 (05) : 545 - 551
  • [29] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    Bouscary, D
    DeVos, J
    Guesnu, M
    Jondeau, K
    Viguier, F
    Melle, J
    Picard, F
    Dreyfus, F
    FontenayRoupie, M
    LEUKEMIA, 1997, 11 (06) : 839 - 845
  • [30] Comparison of Fas(Apo-1/CD95)- and perforin-mediated cytotoxicity in primary T lymphocytes
    Lowin, B
    Mattman, C
    Hahne, M
    Tschopp, J
    INTERNATIONAL IMMUNOLOGY, 1996, 8 (01) : 57 - 63